Oxygenta Pharmaceutical Ltd board meeting
Monday, 27 July 2026
- Purpose
- Results
- Period
- Q1FY26 + FY26
- Company
- Oxygenta Pharmaceutical Ltd (BSE 524636)
Source filings
- Un-audited Financial results for the Quarter ended 30.06.2026. — filed 27 Jul 2026 · Open filing
Sign in free to track Oxygenta Pharmaceutical Ltd and receive future filing alerts.